Literature DB >> 10185145

Management of lung cancer.

A Melville1, A Eastwood.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 10185145      PMCID: PMC2483609          DOI: 10.1136/qshc.7.3.170

Source DB:  PubMed          Journal:  Qual Health Care        ISSN: 0963-8172


× No keyword cloud information.
  135 in total

Review 1.  The role of economics in the evaluation of hospice care.

Authors:  M Goddard
Journal:  Health Policy       Date:  1989-10       Impact factor: 2.980

2.  The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer.

Authors:  W K Evans; T Le Chevalier
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

Review 3.  Duration of chemotherapy in small cell lung cancer.

Authors:  S G Spiro; R L Souhami
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

4.  A randomized clinical trial of home nursing care for lung cancer patients.

Authors:  R McCorkle; J Q Benoliel; G Donaldson; F Georgiadou; C Moinpour; B Goodell
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

5.  Pleuroperitoneal shunt for recurrent malignant pleural effusions.

Authors:  V Tsang; H C Fernando; P Goldstraw
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

6.  Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.

Authors:  M D Brundage; J R Davidson; W J Mackillop
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

7.  Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.

Authors:  L Jaakkimainen; P J Goodwin; J Pater; P Warde; N Murray; E Rapp
Journal:  J Clin Oncol       Date:  1990-08       Impact factor: 44.544

8.  Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.

Authors:  D M Geddes; L Dones; E Hill; K Law; P G Harper; S G Spiro; J S Tobias; R L Souhami
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

9.  An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting.

Authors:  I T Jantunen; V V Kataja; T T Muhonen
Journal:  Eur J Cancer       Date:  1997-01       Impact factor: 9.162

10.  Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?

Authors:  I Higginson; M McCarthy
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.